Table 2.
Upregulated or downregulated “immune” pathways in myasthenia gravis (MG).
| Name | NES | P-value |
|---|---|---|
| Suppressed pathways in MG(+) cases in type AB thymoma | ||
| HALLMARK_TNFA_SIGNALING_VIA_NFKB | −2.09 | 0.0015 |
| MacTh1_cluster | −2.12 | 0.0020 |
| KEGG_CHEMOKINE_SIGNALING_PATHWAY | −1.535 | 0.0070 |
| Activated pathways in MG(+) cases in type B2 thymoma | ||
| T_Cell_cluster_Iglesia | 2.315 | 0.0031 |
| MacTh1_cluster | 2.24 | 0.0031 |
| LCK_Median | 2.07 | 0.0031 |
| UNC_MCD3_CD8 | 2.015 | 0.0050 |
| CD8_cluster | 2.145 | 0.0054 |
NES, normalized enrichment score; P-value, adjustd P-value.
Both NES and P-value are mean score (or value) between that of TdT-low and -high groups.